On 9/11, FDA Approved New Monovalent COVID-19 Shot Against Current Variant for 12+ Year Olds and EUA-Authorizes Age 6 Months to 11 Years with No Clinical Trial
The only basis was "manufacturing data"
Yesterday, the FDA approved (12 year olds and older) & EUA-authorized (6 months to 11 year olds) for a new monovalent COVID-19 shot, based on “manufacturing data” and no clinical trial.
They posted it yesterday, on 9/11.
From the FDA Website, Posted Yesterday
Emphases, headings, and some new paragraph indents are mine.
Today, the U.S. Food and Drug Administration took action approving and
Keep reading with a 7-day free trial
Subscribe to The Rebel Patient™ to keep reading this post and get 7 days of free access to the full post archives.